These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37975370)

  • 21. Hub Long Noncoding RNAs with m6A Modification for Signatures and Prognostic Values in Kidney Renal Clear Cell Carcinoma.
    Lin G; Wang H; Wu Y; Wang K; Li G
    Front Mol Biosci; 2021; 8():682471. PubMed ID: 34295922
    [No Abstract]   [Full Text] [Related]  

  • 22. Construction and Validation of Pyroptosis-Related lncRNA Prediction Model for Colon Adenocarcinoma and Immune Infiltration Analysis.
    Liu Q; Chen N; Liu L; Zheng Q; Liao W; Zhao M; Zeng J; Tang J
    Dis Markers; 2022; 2022():4492608. PubMed ID: 36168326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a novel colon adenocarcinoma m6A-related lncRNA pair prognostic model.
    Liang S; Qiu X; Cai L; Wei F; Huang J; Liu S
    Transl Cancer Res; 2024 Jul; 13(7):3704-3717. PubMed ID: 39145089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of disulfidptosis-related lncRNA signature for predicting the prognosis and immune escape in colon adenocarcinoma.
    Chen P; Yu J; Luo Q; Li J; Wang W
    BMC Gastroenterol; 2023 Nov; 23(1):382. PubMed ID: 37946148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of lncRNA-m6A gene-mRNA regulatory network to identify m6A-related lncRNAs associated with the progression of lung adenocarcinoma.
    Zhang J; Bai S; Yan Y; Kang H; Li G; Feng Z; Ma W; Wang X; Ren J
    BMC Pulm Med; 2023 Aug; 23(1):284. PubMed ID: 37537521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
    Song Y; Qu H
    BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-6 methylation-related lncRNA is potential signature in lung adenocarcinoma and influences tumor microenvironment.
    Zheng J; Zhao Z; Wan J; Guo M; Wang Y; Yang Z; Li Z; Ming L; Qin Z
    J Clin Lab Anal; 2021 Nov; 35(11):e23951. PubMed ID: 34558724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and validation of the potential biomarkers based on m6A-related lncRNAs for the predictions of overall survival in the lung adenocarcinoma and differential analysis with cuproptosis.
    Gao C; Kong N; Zhang F; Zhou L; Xu M; Wu L
    BMC Bioinformatics; 2022 Aug; 23(1):327. PubMed ID: 35941550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of a ferroptosis-related lncRNAs prognosis signature in colon cancer.
    Cai HJ; Zhuang ZC; Wu Y; Zhang YY; Liu X; Zhuang JF; Yang YF; Gao Y; Chen B; Guan GX
    Bosn J Basic Med Sci; 2021 Oct; 21(5):569-576. PubMed ID: 33714257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y
    Front Oncol; 2022; 12():876660. PubMed ID: 35747790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.
    He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q
    Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism-related lncRNAs signature to predict the prognosis of colon adenocarcinoma.
    Sun Y; Liu B; Xiao B; Jiang X; Xiang JJ; Xie J; Hu XM
    Cancer Med; 2023 Mar; 12(5):5994-6008. PubMed ID: 36366731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognosis prediction model based on competing endogenous RNAs for recurrence of colon adenocarcinoma.
    Jin LP; Liu T; Meng FQ; Tai JD
    BMC Cancer; 2020 Oct; 20(1):968. PubMed ID: 33028275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. m6A-related lncRNA-based immune infiltration characteristic analysis and prognostic model for colonic adenocarcinoma.
    Wang HL; Ye ZM; He ZY; Huang L; Liu ZH
    Hereditas; 2023 Feb; 160(1):6. PubMed ID: 36755298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of key lncRNAs in the carcinogenesis and progression of colon adenocarcinoma by co-expression network analysis.
    Jiang S; Tan B; Zhang X
    J Cell Biochem; 2019 Apr; 120(4):6490-6501. PubMed ID: 30430631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
    Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D
    Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential Prognostic Value of a Seven m6A-Related LncRNAs Signature and the Correlative Immune Infiltration in Colon Adenocarcinoma.
    Chai XK; Qi W; Zou CY; He CX; Su M; Zhao DQ
    Front Genet; 2021; 12():774010. PubMed ID: 35003214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
    Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C
    BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. m6A-related long noncoding RNAs predict prognosis and indicate therapeutic response in endometrial carcinoma.
    Zhou X; Zhang H; Duan Y; Zhu J; Dai H
    J Clin Lab Anal; 2023 Jan; 37(1):e24813. PubMed ID: 36525280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disulfidptosis-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in colon adenocarcinoma.
    Xue W; Qiu K; Dong B; Guo D; Fu J; Zhu C; Niu Z
    Cancer Cell Int; 2023 Sep; 23(1):218. PubMed ID: 37759294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.